UPDATE : Tuesday, April 7, 2020
ViroMed starts trial on VM202’s effect on peripheral artery disease by Lee Han-soo 2017-12-05 15:40
Shares of biotech firms, listed with ‘exceptional techs,’ rise above offer price by Nam Doo-hyun 2017-12-05 14:38
Sewon seeks p3 clinical trials for cartilage cell therapy in Japan by Lee Han-soo 2017-12-04 16:17
Cord blood biotech firms enjoy stock price gains this year by Nam Doo-hyun 2017-12-04 15:02
Nature Cell’s clinical trial on Alzheimer therapy running smoothly by Lee Han-soo 2017-12-04 14:57
FDA approves clinical trial for Pharmicell’s liver cirrhosis treatment by Lee Han-soo 2017-12-04 14:57
Tego Science shares surge on robust earnings by Nam Doo-hyun 2017-12-01 11:48
Panagene wins patent for molecular diagnostic platform by Lee Han-soo 2017-12-01 11:02
Medipost hits record vial sales for Cartistem by Lee Han-soo 2017-11-30 16:16
Biopharmaceutical firms' liver treatments draw attention by So Jae-hyeon 2017-11-30 12:02
What are doctors’ views on Invossa used even by foreign patients? by Lee Hye-seon 2017-11-29 09:31
Green Cross, Feldan start joint tech development by Lee Han-soo 2017-11-27 16:59
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed by Nam Doo-hyun 2017-11-27 13:13
Biogen Korea taps new CEO by Marian Chu 2017-11-27 11:57
Clinical trials on CAR-T cell therapies surge in two years by Nam Doo-hyun 2017-11-24 15:53
Kolon okayed for clinical trial to expand treatment for Invossa-K injection by Lee Han-soo 2017-11-23 15:53
GemVax & KAEL confirms potential tracer effective to reperfusion injury by Constance Williams 2017-11-22 15:51
COGIB spotlights future of innovative biotherapeutic by Lee Han-soo 2017-11-22 11:06
KAEL confirms potential tracer as treatment for kidney cancer by Constance Williams 2017-11-20 15:44
Samsung Bioepis wins European sales approval for Ontruzant by Lee Han-soo 2017-11-20 10:48
Back to Top